ARCA biopharma, Inc. Made Headway
Thu, Aug 29, 2024 at 07:41 PM
ARCA biopharma, Inc. (ABIO:NASDAQ) jumped higher at $2.5, a gain of 32.5%. On Thu, Aug 29, 2024, ABIO:NASDAQ touched a New 2-Week Low of $2.5. The stock appeared on our News Catalysts scanner on Thu, Aug 29, 2024 at 06:03 PM in the 'MERGER' category. From Thu, Aug 15, 2024, the stock recorded 70.00% Up Days and 63.64% Green Days
About ARCA biopharma, Inc. (ABIO:NASDAQ)
ARCA biopharma Inc is a biopharmaceutical company. The Company is engaged in developing genetically-targeted therapies for cardiovascular diseases. Its product candidate is Gencaro.
Top 10 Gainers:
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 130.77%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 60%
- Innovative Eyewear Inc. (LUCY:NASDAQ), 53.78%
- Movella Holdings Inc Com (MVLA:NASDAQ), 49%
- Singularity Future Technology Ltd. (SGLY:NASDAQ), 39.86%
- Raytech Holding Limited (RAY:NASDAQ), 38.67%
- Theriva Biologics Inc Com Par $.001 (TOVX:NYSEMKT), 34.29%
- ARCA biopharma, Inc. (ABIO:NASDAQ), 32.49%
- Affirm Holdings Inc. (AFRM:NASDAQ), 31.92%
- TC BioPharm (Holdings) plc (TCBP:NASDAQ), 30.24%